HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Midkine is expressed by infiltrating macrophages in in-stent restenosis in hypercholesterolemic rabbits.

AbstractBACKGROUND:
Neointimal hyperplasia is strikingly suppressed in an endothelium injury model in mice deficient in the growth factor midkine. Knockdown of midkine expression by means of antisense oligonucleotide or small interfering RNA has been shown to lead to suppression of neointimal hyperplasia in a balloon injury model and a rabbit vein graft model; therefore, midkine is an essential factor for neointimal hyperplasia. These findings, however, do not necessarily apply to the function of midkine in vascular stenoses such as in-stent restenosis, because human vascular stenosis is often accompanied by atherosclerosis.
METHODS:
We investigated midkine expression in the neointima induced by implantation of a bare metal stent in the atheromatous lesions of hypercholesterolemic rabbits. We analyzed midkine expression during a THP-1 cell differentiation and in peritoneal macrophages exposed to low-density lipoprotein or oxidized low-density lipoprotein.
RESULTS:
Midkine expression reached the maximum level within 7 days after stenting and was detected in infiltrating macrophages. Differentiation of THP-1 cells to macrophage-like cells did not trigger midkine expression. Neither low-density lipoprotein nor oxidized low-density lipoprotein enhanced midkine expression in peritoneal macrophages that had been activated by thioglycollate, although these cells expressed a significant amount of midkine.
CONCLUSION:
The results indicate that macrophages are the major source of midkine in the atherosclerotic neointima. The amount of midkine expressed in macrophages may be sufficient (ie, further enhancement of the expression is not necessary) for the pathogenesis, because oxidized low-density lipoprotein stimulation did not induce the midkine expression.
CLINICAL RELEVANCE:
The growth factor midkine is induced during vascular stenosis in mouse and rat models with normal diet. Knockdown of midkine expression suppresses neointimal hyperplasia. The vascular response after stenting differs from that after balloon injury in that the inflammation is more prolonged and the accumulation of macrophages is more abundant in stent-injured vessel. We found here that macrophages are the major source of midkine in the atherosclerotic neointima of in-stent restenosis in hypercholesterolemic rabbits. Our data suggest that midkine has an important role in in-stent restenosis of atherosclerotic vessels and is a candidate molecular target to prevent in-stent restenosis.
AuthorsHiroshi Narita, Sen Chen, Kimihiro Komori, Kenji Kadomatsu
JournalJournal of vascular surgery (J Vasc Surg) Vol. 47 Issue 6 Pg. 1322-9 (Jun 2008) ISSN: 0741-5214 [Print] United States
PMID18353604 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cholesterol, Dietary
  • Cytokines
  • Lipoproteins, LDL
  • Metals
  • oxidized low density lipoprotein
  • Midkine
Topics
  • Angioplasty, Balloon (instrumentation)
  • Animals
  • Atherosclerosis (etiology, immunology, metabolism, pathology, therapy)
  • Cell Differentiation
  • Cell Line
  • Cell Movement
  • Cells, Cultured
  • Cholesterol, Dietary (administration & dosage)
  • Constriction, Pathologic
  • Cytokines (metabolism)
  • Disease Models, Animal
  • Humans
  • Hypercholesterolemia (complications, etiology, immunology, metabolism, pathology)
  • Hyperplasia
  • Iliac Artery (immunology, metabolism, pathology)
  • Lipoproteins, LDL (metabolism)
  • Macrophages (immunology, metabolism)
  • Male
  • Metals
  • Mice
  • Midkine
  • Prosthesis Design
  • Rabbits
  • Stents
  • Time Factors
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: